Skip to main content
. 2017 Sep 5;114(38):10220–10225. doi: 10.1073/pnas.1706689114

Fig. 5.

Fig. 5.

The combination of [18F]-CFA PET and advanced MRI can help distinguish tumor progression from inflammation in patients with GBM treated with DC vaccination and PD-1 mAb blockade. Postcontrast T1-weighted, T1-subtraction, relative CBV, ADC, [18F]-FAC PET + MRI fusion, and whole-body maximum-intensity projection images of [18F]-CFA from two patients (A, patient A; B, patient B) with recurrent GBM before (Top) and after (Bottom) immunotherapy.